Search research articles
Contact Us
Filters
Showing results (331-340 of 437) with videos related to
Page
of 44
Sort By:
G3 (Bethesda, Md.)
|
December 13, 2021
NLR diversity and candidate fusiform rust resistance genes in loblolly pine
Daniel Ence, Katherine E Smith, Shenghua Fan, et al.
Arthritis and Rheumatism
|
March 9, 2011
A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis
John M Davis, Keith L Knutson, Michael A Strausbauch, et al.
Schizophrenia Bulletin Open
|
February 15, 2021
Concordance of Immune-Related Markers in Lymphocytes and Prefrontal Cortex in Schizophrenia
Eleonora Gatta, Vikram Saudagar, Jenny Drnevich, et al.
Arthritis Care & Research
|
December 4, 2018
Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study
Divya N V Challa, Zoran Kvrgic, Cynthia S Crowson, et al.
Seminars in Arthritis and Rheumatism
|
January 10, 2022
Time to transition from psoriasis to psoriatic arthritis: A population-based study
Paras Karmacharya, Kerry Wright, Sara J Achenbach, et al.
Lancet (London, England)
|
February 27, 2022
Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
Johannes Schneider-Thoma, Konstantina Chalkou, Carola Dörries, et al.
The Journal of Clinical Psychiatry
|
August 3, 2022
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial
Linda Levi, Daisy Zamora, Igor Nastas, et al.
The American Journal of Psychiatry
|
May 26, 2017
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors
Stefan Leucht, Claudia Leucht, Maximilian Huhn, et al.
Seminars in Arthritis and Rheumatism
|
September 19, 2019
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire
Elena Myasoedova, Annette De Thurah, Marie-Line Erpelding, et al.
Schizophrenia Research
|
July 2, 2026
Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals
Yu Dong, Jiaxi Wang, Shiwei Guan, et al.
Page
of 44
Search research articles
Search
Showing results (331-340 of 437) with videos related to
Sort By:
Page
of 44
G3 (Bethesda, Md.)
|
December 13, 2021
NLR diversity and candidate fusiform rust resistance genes in loblolly pine
Daniel Ence, Katherine E Smith, Shenghua Fan, et al.
Arthritis and Rheumatism
|
March 9, 2011
A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis
John M Davis, Keith L Knutson, Michael A Strausbauch, et al.
Schizophrenia Bulletin Open
|
February 15, 2021
Concordance of Immune-Related Markers in Lymphocytes and Prefrontal Cortex in Schizophrenia
Eleonora Gatta, Vikram Saudagar, Jenny Drnevich, et al.
Arthritis Care & Research
|
December 4, 2018
Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study
Divya N V Challa, Zoran Kvrgic, Cynthia S Crowson, et al.
Seminars in Arthritis and Rheumatism
|
January 10, 2022
Time to transition from psoriasis to psoriatic arthritis: A population-based study
Paras Karmacharya, Kerry Wright, Sara J Achenbach, et al.
Lancet (London, England)
|
February 27, 2022
Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
Johannes Schneider-Thoma, Konstantina Chalkou, Carola Dörries, et al.
The Journal of Clinical Psychiatry
|
August 3, 2022
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial
Linda Levi, Daisy Zamora, Igor Nastas, et al.
The American Journal of Psychiatry
|
May 26, 2017
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors
Stefan Leucht, Claudia Leucht, Maximilian Huhn, et al.
Seminars in Arthritis and Rheumatism
|
September 19, 2019
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire
Elena Myasoedova, Annette De Thurah, Marie-Line Erpelding, et al.
Schizophrenia Research
|
July 2, 2026
Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals
Yu Dong, Jiaxi Wang, Shiwei Guan, et al.
Page
of 44